In tumor tissue from patients who showed a clinical response to PD1 ICB, the expression of the CD8+ T-cell gene set correlated with the gene sets of cDC2s, pDCs and monocyte activation (figure 4G). The gene discussed is CD8A; the disease is neoplasm.